Free Trial

Theratechnologies (THTX) Competitors

Theratechnologies logo
$3.17 +0.02 (+0.63%)
Closing price 04:00 PM Eastern
Extended Trading
$3.17 0.00 (0.00%)
As of 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

THTX vs. TYRA, PGEN, ARVN, TBPH, SAGE, ORGO, TSHA, ABVX, BCYC, and BCAX

Should you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include Tyra Biosciences (TYRA), Precigen (PGEN), Arvinas (ARVN), Theravance Biopharma (TBPH), Sage Therapeutics (SAGE), Organogenesis (ORGO), Taysha Gene Therapies (TSHA), Abivax (ABVX), Bicycle Therapeutics (BCYC), and Bicara Therapeutics (BCAX). These companies are all part of the "pharmaceutical products" industry.

Theratechnologies vs. Its Competitors

Tyra Biosciences (NASDAQ:TYRA) and Theratechnologies (NASDAQ:THTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

Tyra Biosciences has a net margin of 0.00% compared to Theratechnologies' net margin of -10.85%. Theratechnologies' return on equity of 0.00% beat Tyra Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Tyra BiosciencesN/A -26.90% -25.54%
Theratechnologies -10.85%N/A -9.83%

Tyra Biosciences has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500.

In the previous week, Tyra Biosciences had 1 more articles in the media than Theratechnologies. MarketBeat recorded 3 mentions for Tyra Biosciences and 2 mentions for Theratechnologies. Theratechnologies' average media sentiment score of 1.78 beat Tyra Biosciences' score of 0.62 indicating that Theratechnologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tyra Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Theratechnologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Theratechnologies has higher revenue and earnings than Tyra Biosciences. Theratechnologies is trading at a lower price-to-earnings ratio than Tyra Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tyra BiosciencesN/AN/A-$86.48M-$1.63-6.79
Theratechnologies$85.87M1.70-$8.31M-$0.19-16.68

Tyra Biosciences currently has a consensus price target of $30.83, indicating a potential upside of 178.78%. Given Tyra Biosciences' higher probable upside, analysts clearly believe Tyra Biosciences is more favorable than Theratechnologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tyra Biosciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Theratechnologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
3.00

84.1% of Tyra Biosciences shares are owned by institutional investors. 15.2% of Tyra Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Tyra Biosciences beats Theratechnologies on 8 of the 15 factors compared between the two stocks.

Get Theratechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THTX vs. The Competition

MetricTheratechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$144.84M$3.07B$5.70B$9.51B
Dividend YieldN/A2.36%4.69%4.01%
P/E Ratio-16.6821.0428.0720.05
Price / Sales1.70284.46448.5799.42
Price / CashN/A42.7636.2258.56
Price / Book-5.208.378.665.87
Net Income-$8.31M-$55.19M$3.25B$258.55M
7 Day Performance0.96%5.89%4.20%2.23%
1 Month Performance29.92%17.63%10.82%12.76%
1 Year Performance119.38%5.09%34.70%19.36%

Theratechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THTX
Theratechnologies
N/A$3.17
+0.6%
N/A+117.2%$144.84M$85.87M-16.68140
TYRA
Tyra Biosciences
3.1242 of 5 stars
$10.91
+6.3%
$30.83
+182.6%
-48.6%$579.21MN/A-6.6920
PGEN
Precigen
3.8466 of 5 stars
$1.95
+6.6%
$6.00
+207.7%
-2.1%$575.60M$4.20M-3.48190Positive News
ARVN
Arvinas
4.0032 of 5 stars
$7.87
+1.0%
$20.29
+157.8%
-72.7%$574.43M$263.40M-11.92420News Coverage
Upcoming Earnings
TBPH
Theravance Biopharma
1.7803 of 5 stars
$11.47
+1.5%
$16.60
+44.7%
+11.3%$573.50M$64.38M-9.72110
SAGE
Sage Therapeutics
3.4224 of 5 stars
$9.15
-1.3%
$8.75
-4.4%
-15.6%$572.97M$41.24M-1.58690Upcoming Earnings
ORGO
Organogenesis
4.5372 of 5 stars
$4.49
+4.4%
$6.00
+33.6%
+53.2%$569.56M$482.04M-26.41950
TSHA
Taysha Gene Therapies
4.2565 of 5 stars
$2.64
flat
$8.17
+209.3%
+15.6%$566.70M$8.33M-7.76180
ABVX
Abivax
2.4067 of 5 stars
$8.83
+6.8%
$31.00
+251.1%
+488.7%$560.44MN/A0.0061Trending News
Analyst Forecast
Analyst Revision
Gap Down
High Trading Volume
BCYC
Bicycle Therapeutics
3.8213 of 5 stars
$8.08
+1.0%
$25.00
+209.4%
-63.5%$559.54M$35.28M-2.57240
BCAX
Bicara Therapeutics
2.0924 of 5 stars
$10.18
+4.8%
$31.86
+213.0%
N/A$555.22MN/A0.0032

Related Companies and Tools


This page (NASDAQ:THTX) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners